http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2643763-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32a8fdefdbceddebe2c593b6a47b722c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 |
| filingDate | 2011-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5fa0cfb4310724fb87580439709e936 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ba073ffe73db34aff00cf766d8cb10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c93625ef3e943911ac2d6b8f41eb3002 |
| publicationDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2643763-C2 |
| titleOfInvention | Polyethylene glycol compositions for control of relapses of labial herpes, genital herpes and herpes zoster |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: invention relates to pharmaceutical industry, namely to method for reducing the frequency of relapses of labial herpes in patient, which comprises topical administration of therapeutically effective amount of polyethylene glycol (PEG) as an active agent, which is either (i) PEG with average molecular weight of 200–800, or (ii) mixture of (a) PEG with average molecular weight of 200–800 and (b) PEG with average molecular weight of 1000–15000, wherein the weight ratio (a) to (b) ranges from 3:1 to 20:1, wherein said method is performed for at least 4 weeks; topical administration is carried out 1–5 times a day on the lips and/or around the lips of the patient. n EFFECT: invention provides reduction or prevention of relapses of labial herpes. n 53 cl, 1 ex, 9 tbl, 1 dwg |
| priorityDate | 2010-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 580.